Sevilla-Movilla S, Arellano-Sánchez N, Martínez-Moreno M, Gajate C, Sánchez-Vencells A, Vitores Valcárcel L, Agirre X, Valeri A, Martínez-López J, Prósper F,Mollinedo F and Teixidó J.
[2020]. Upregulated expression and function of the a4b1 integrin in multiple myeloma cells resistant to bortezomib. J. Pathol. 252: 29-40
Benito-Jardón L, Díaz-Martínez M, Arellano-Sánchez N, Vaquero-Morales P, Esparis-Ogando A and Teixidó J
[2019]. Resistance to MAPK inhibitors in melanoma involves activation of the IGF-1R-MEK5-Erk5 pathway. Cancer Res. 79(9): 2244-2256
Redondo-Muñoz J, García-Pardo A and Teixidó J
[2019]. Molecular players in hematological tumor cell trafficking. Frontiers in Immunol. 10:156
Teixidó J, Martínez-Moreno M, Díaz-Martínez M and Sevilla-Movilla S.
[2018]. The good and bad faces of the CXCR4 chemokine receptor. Internat. J. Biochem. Cell Biol. 95: 121-131
Díaz-Martínez M, Benito-Jardón L, Alonso L, Koetz-Ploch L, Hernando E, Teixido J.
[2018]. miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma. Cancer Research, 78: 1017-1030.
Teixidó J, Martínez-Moreno M, Díaz-Martínez M, Sevilla-Movilla S.
[2017]. The good and bad faces of the CXCR4 chemokine receptor. Int J Biochem Cell Biol. 95:121-131
Bartolomé RA, Torres S, Isern de Val S, Escudero-Paniagua B, Calviño E, Teixidó J, Casal JI.
[2017]. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers. Oncotarget. 8: 215-227.
Sosa-Costa A, Isern de Val S, Sevilla-Movilla S, Borgman KJ, Manzo C, Teixidó J, Garcia-Parajo MF.
[2016]. Lateral Mobility and Nanoscale Spatial Arrangement of Chemokine-activated α4β1 Integrins on T Cells. J Biol Chem. 291: 21053-21062
Gutiérrez-González A, Martínez-Moreno M, Samaniego R, Arellano-Sánchez N, Salinas-Muñoz L, Relloso M, Valeri A, Martínez-López J, Corbí ÁL, Hidalgo A, García-Pardo Á, Teixidó J, Sánchez-Mateos P.
[2016]. Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma. Blood. 128: 2241-2252
M Martínez-Moreno, M Leiva, N Aguilera-Montilla, S Sevilla-Movilla, S I de Val, N Arellano-Sánchez, N C Gutiérrez, R Maldonado, J Martínez-López, I Buño, J A García-Marco, P Sánchez-Mateos, A Hidalgo, A García-Pardo and J Teixidó
[2016]. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins. 2016. Leukemia, 30, 861-872
Dios-Esponera A, Isern de Val S, Sevilla-Movilla S, García-Verdugo R, García-Bernal D, Arellano-Sánchez N, Cabañas C, Teixidó J.
[2015]. Positive and negative regulation by SLP-76/ADAP and Pyk2 of chemokine-stimulated T lymphocyte adhesion mediated by integrin α4β1. Mol Biol Cell. 2015 Jul 22. pii: mbc.E14-07-1246. PMID: 26202465
Bartolomé R.A., Díaz-Martínez M., Coló G.P., Arellano-Sánchez N., Torres-Ayuso P., Kleinovink J.W., Mérida I. y Teixidó J.
[2014]. A Blk-p190RhoGAP signaling module downstream of activated Gα13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion. Cell Signal. 2014 Nov;26(11):2551-61. doi: 10.1016/j.cellsig.2014.07.008. Epub 2014 Jul 13. PMID: 25025568
Coló GP, Hernández-Varas P, Lock J, Bartolomé RA, Arellano-Sánchez N, Strömblad S, Teixidó J.
[2012]. Focal adhesion disassembly is regulated by a RIAM to MEK-1 pathway. J Cell Sci. 2012 Nov 15;125(Pt 22):5338-52. doi: 10.1242/jcs.105270. Epub 2012 Sep 3. PMID: 22946047
García-Bernal D, Redondo-Muñoz J, Dios-Esponera A, Chèvre R, Bailón E, Garayoa M, Arellano-Sánchez N, Gutierrez NC, Hidalgo A, García-Pardo A, Teixidó J
[2012]. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function. J Pathol. 2013 Jan;229(1):36-48. doi: 10.1002/path.4066.
Coló GP, Lafuente EM, Teixidó J
[2012]. The MRL proteins: Adapting cell adhesion, migration and growth. Eur J Cell Biol. 2012 Nov;91(11-12):861-8. 2012 May 1
García-Bernal D, Dios-Esponera A, Sotillo-Mallo E, García-Verdugo R, Arellano-Sánchez N, Teixidó J.
[2011]. RGS10 restricts upregulation by chemokines of T cell adhesion mediated by α4β1 and αLβ2 Integrins. J Immunol. 2011 Aug 1;187(3):1264-72. 2011 Jun 24.
